Repeat laser eye treatment study for eligible prior participants
Part of Eyes & vision clinical trials.
This study is for people who already joined an earlier selective laser eye treatment trial and were able to be followed without needing stronger additional treatments. It looks at the best plan for repeating the laser treatment when appropriate.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have been part of the original OSLT (selective laser trabeculoplasty) trial
- You must have follow-up where you did not need any other escalation treatment beyond a repeat laser
- You must be able to attend follow-up visits for the study
- You must be physically able to participate and complete study steps
- You must be able to stay in the area enough to do the required follow-up
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a specific eye laser treatment (micropulse) for people with open-angle or pseudoexfoliation glaucoma. It may help lower eye pressure, and the study also checks whether patients can follow the treatment plan and follow-up visits.
This trial tests a special laser treatment called Direct Selective Laser Trabeculoplasty (DSLT) for people with pseudoexfoliation glaucoma, a type of glaucoma that can be harder to treat. The treatment aims to lower eye pressure and may help delay or avoid the need for daily eye drops.
This trial tests a new laser treatment called DSLT for people with normal-tension glaucoma, a type of glaucoma where eye pressure is normal but vision is still damaged. It aims to lower eye pressure and help preserve vision. The study is specifically for people of Asian descent.
This trial compares cataract surgery (phacoemulsification) versus a laser treatment (SLT) as the first treatment for pseudoexfoliation glaucoma. It aims to find which approach lowers eye pressure and helps prevent progression for people with early disease and cataracts.
This trial is testing a laser treatment called DSLT to see if it can help people with glaucoma use fewer eye drops. It may be a good option if your eye pressure is already controlled with medication and you haven't had glaucoma surgery before.
This Phase 3 study tests how best to use a laser treatment (SLT) for people with high eye pressure or mild-to-moderate primary open-angle glaucoma. It aims to find the best way to lower eye pressure and protect vision while comparing treatment approaches.
Hear when a new Glaucoma, Open-Angle trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.